GlassScriptPhysician profile
Divya Chauhan
NPI 1487920658
$4,232.85
in general payments reported to CMS, 2019-2025
11 companies · $1,110 in 2025
The $1,110 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $75.85 · 2021: $619 · 2022: $1,042 · 2023: $67.18 · 2024: $971 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,628 · Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,627.50 |
| Food and Beverage | $519.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,307.38 | 2020-2025 | Fasenra |
| Glaxosmithkline, LLC. | $676.02 | 2019-2024 | Nucala |
| Genzyme Corporation | $537.42 | 2021-2025 | |
| Regeneron Pharmaceuticals, INC. | $427.07 | 2022-2025 | Dupixent |
| Teva Pharmaceuticals USA, INC. | $121.40 | 2019-2022 | |
| Kaleo, INC. | $43.40 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.59 | 2021 | |
| Pharming Healthcare, INC. | $27.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.42 | 2022 | |
| Mylan Specialty L.P. | $18.66 | 2021 | |
| Grifols USA, LLC | $18.13 | 2025 | Xembify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Chauhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.